Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c)

Human Molecular Genetics

Volumn 15, Issue 7, 2006, Pages 1059-1070

  Scoles, Daniel R ^a,b,c   Yong, William H ^b   Qin, Yun ^a   Wawrowsky, Kolja ^a   Pulst, Stefan Matthias ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 3; MERLIN; PROTEIN P110; PROTEIN SUBUNIT;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; HUMAN; HUMAN CELL; MENINGIOMA; NEUROFIBROMATOSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION;

ADULT; CELL LINE, TRANSFORMED; CELL PROLIFERATION; EUKARYOTIC INITIATION FACTOR-3; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; MENINGIOMA; MODELS, BIOLOGICAL; NEUROFIBROMATOSES; NEUROFIBROMIN 2; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EUKARYOTA;

EID: 33645119208     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl021     Document Type: Article

References (48)

1. Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kley, N., Menon, A.G., Pulaski, K. et al. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 75, 791-800.
2. Rouleau, G.A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B. et al. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature, 363, 515-521.
3. Bretscher, A., Edwards, K. and Fehon, R.G. (2002) ERM proteins and merlin: Integrators at the cell cortex. Nat. Rev. Mol. Cell Biol., 3, 586-599.
4. Sun, C.X., Robb, V.A. and Gutmann, D.H. (2002) Protein 4.1 tumor suppressors: Getting a FERM grip on growth regulation. J. Cell Sci., 115, 3991-4000.
5. Gonzalez-Agosti, C., Wiederhold, T., Herndon, M.E., Gusella, J. and Ramesh, V. (1999) Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF. J. Biol. Chem., 274, 34438-34442.
6. Scherer, S.S. and Gutmann, D.H. (1996) Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J. Neurosci. Res., 46, 595-605.
7. Sherman, L., Xu, H.M., Geist, R.T., Saporito-Irwin, S., Howells, N., Ponta, H., Herrlich, P. and Gutmann, D.H. (1997) Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene, 15, 2505-2509.
8. Lutchman, M. and Rouleau, G.A. (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res., 55, 2270-2274.
9. Gutmann, D.H., Sherman, L., Seftor, L., Haipek, C., Hoang Lu, K. and Hendrix, M. (1999) Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. Hum. Mol. Genet., 8, 267-275.
10. Scoles, D.R., Huynh, D.P., Morcos, P.A., Coulsell, E.R., Robinson, N.G., Tamanoi, F. and Pulst, S.M. (1998) Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat. Genet., 18, 354-359.
11. Huynh, D.P. and Pulst, S.M. (1996) Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells. Oncogene, 13, 73-84.
12. Lallemand, D., Curto, M., Saotome, I., Giovannini, M. and McClatchey, A.I. (2003) NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev., 17, 1090-1100.
13. Rangwala, R., Banine, F., Borg, J.P., and Sherman, L.S. (2005) Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between merlin and adherens junction protein complexes in Schwann cells. J. Biol. Chem., 280, 11790-11797.
14. Pelton, P.D., Sherman, L.S., Rizvi, T.A., Marchionni, M.A., Wood, P., Friedman, R.A. and Ratner, N. (1998) Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene, 17, 2195-2209.
15. Shaw, R.J., Paez, J.G., Curto, M., Yaktine, A., Pruitt, W.M., Saotome, I., O'Bryan, J.P., Gupta, V., Ratner, N., Der, C.J., Jacks, T. and McClatchey, A.I. (2001) The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev. Cell, 1, 63-72.
16. Murthy, A., Gonzalez-Agosti, C., Cordero, E., Pinney, D., Candia, C., Solomon, F., Gusella, J. and Ramesh, V. (1998) NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J. Biol. Chem., 273, 1273-1276.
17. Sainio, M., Zhao, F., Heiska, L., Turunen, O., den Bakker, M., Zwarthoff, E., Lutchman, M., Rouleau, G.A., Jaaskelainen, J., Vaheri, A. and Carpen, O. (1997) Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J. Cell Sci., 110, 2249-2260.
18. Manchanda, N., Lyubimova, A., Ho, H.Y., James, M.F., Gusella, J.F., Ramesh, N., Snapper, S.B. and Ramesh, V. (2005) The NF2 tumor suppressor merlin and the ERM proteins interact with N-wasp and regulate its actin polymerization function. J. Biol. Chem., 280, 12517-12522.
19. Fernandez-Valle, C., Tang, Y., Ricard, J., Rodenas-Ruano, A., Taylor, A., Hackler, E., Biggerstaff, J. and Iacovelli, J. (2002) Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat. Genet., 31, 354-362.
20. Scoles, D.R., Huynh, D.P., Chen, M.S., Burke, S.P., Gutmann, D.H. and Pulst, S.M. (2000) The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Hum. Mol. Genet., 9, 1567-1574.
21. Scoles, D.R., Nguyen, V.D., Qin, Y., Sun, C.X., Morrison, H., Gutmann, D.H. and Pulst, S.M. (2002) Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling. Hum. Mol. Genet., 11, 3179-3189.
22. Scoles, D.R., Qin, Y., Nguyen, V., Gutmann, D.H. and Pulst, S.M. (2005) HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line. Biochem. Biophys. Res. Comm., 335, 385-392.
23. Rong, R., Tang, X., Gutmann, D.H. and Ye, K. (2004) Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Proc. Natl Acad. Sci. USA, 101, 18200-18205.
24. Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245-246.
25. Huynh, D.P., Nechiporuk, T. and Pulst, S.M. (1994) Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains. Hum. Mol. Genet., 3, 1075-1079.
26. Seal, S.N., Schmidt, A. and Marcus, A. (1989) Ribosome binding to inosine-substituted mRNAs in the absence of ATP and mRNA factors. J. Biol. Chem., 264, 7363-7368.
27. Gutmann, D.H., Haipek, C.A. and Hoang Lu, K. (1999) Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations. J. Neurosci. Res., 58, 706-716.
28. Ruttledge, M.H., Sarrazin, J., Rangaratnam, S., Phelan, C.M., Twist, E., Merel, P., Delattre, O., Thomas, G., Nordenskjold, M., Collins, V.P. et al. (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat. Genet., 6, 180-184.
29. Sainz, J., Huynh, D.P., Figueroa, K., Ragge, N.K., Baser, M.E. and Pulst, S.M. (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum. Mol. Genet., 3, 885-891.
30. Lee, J.Y., Kim, H., Ryu, C.H., Kim, J.Y., Choi, B.H., Lim, Y., Huh, P.W., Kim, Y.H., Lee, K.H., Jun, T.Y. et al. (2004) Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J. Biol. Chem., 279, 30265-30273.
31. Benkirane, M., Neuveut, C., Chun, R.F., Smith, S.M., Samuel, C.E., Gatignol, A. and Jeang, K.T. (1997) Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J., 16, 611-624.
32. Eckmann, C.R. and Jantsch, M.F. (1997) Xlrbpa, a double-stranded RNA-binding protein associated with ribosomes and heterogeneous nuclear RNPs. J. Cell Biol., 138, 239-253.
33. Park, H., Davies, M.V., Langland, J.O., Chang, H.W., Nam, Y.S., Tartaglia, J., Paoletti, E., Jacobs, B.L., Kaufman, R.J. and Venkatesan, S. (1994) TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl Acad. Sci. USA, 91, 4713-4717.
34. Saramaki, O., Willi, N., Bratt, O., Gasser, T.C., Koivisto, P., Nupponen, N.N., Bubendorf, L. and Visakorpi, T. (2001) Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. Am. J. Pathol., 159, 2089-2094.
35. Nupponen, N.N., Isola, J. and Visakorpi, T. (2000) Mapping the amplification of EIF3S3 in breast and prostate cancer. Genes Chromosomes Cancer, 28, 203-210.
36. Lin, L., Holbro, T., Alonso, G., Gerosa, D. and Burger, M.M. (2001) Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7. J. Cell Biochem., 80, 483-490.
37. Pincheira, R., Chen, Q. and Zhang, J.T. (2001) Identification of a 170-kDa protein over-expressed in lung cancers. Br. J. Cancer, 84, 1520-1527.
38. Mayeur, G.L. and Hershey, J.W. (2002) Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett., 514, 49-54.
39. Asano, K., Merrick, W.C. and Hershey, J.W. (1997) The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome. J. Biol. Chem., 272, 23477-23480.
40. Morris-Desbois, C., Bochard, V., Reynaud, C. and Jalinot, P. (1999) Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies. J. Cell Sci., 112, 3331-3342.
41. Hoareau Alves, K., Bochard, V., Rety, S. and Jalinot, P. (2002) Association of the mammalian proto-oncoprotein Int-6 with the three protein complexes eIF3, COP9 signalosome and 26S proteasome. FEBS Lett., 527, 15-21.
42. Rosenwald, I.B. (1995) Growth factor-independent expression of the gene encoding eukaryotic translation initiation factor 4E in transformed cell lines. Cancer Lett., 98, 77-82.
43. Rosenwald, I.B., Wang, S., Savas, L., Woda, B. and Pullman, J. (2003) Expression of translation initiation factor eIF-2alpha is increased in benign and malignant melanocytic and colonic epithelial neoplasms. Cancer, 98, 1080-1088.
44. Rothe, M., Ko, Y., Albers, P. and Wernert, N. (2000) Eukaryotic initiation factor 3 eIF3c mRNA is overexpressed in testicular seminomas. Am. J. Pathol., 157, 1597-1604.
45. Loftus, B.J., Kim, U.J., Sneddon, V.P., Kalush, F., Brandon, R., Fuhrmann, J., Mason, T., Crosby, M.L., Barnstead, M., Cronin, L. et al. (1999) Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics, 60, 295-308.
46. Inoki, K., Corradetti, M.N. and Guan, K.L. (2005) Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet., 37, 19-24.
47. Dahlberg, W.K., Little, J.B., Fletcher, J.A., Suit, H.D. and Okunief, P. (1993) Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int. J. Radiat. Biol., 63, 191-198.
48. Jares-Erijman, E.A. and Jovin, T.M. (2003) FRET imaging. Nat. Biotechnol., 21, 1387-1395.